3-氯吡嗪-2-甲酸，CAS 登记号 27398-39-6，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3-氯吡嗪-2-甲酸 的 CAS 号：27398-39-6，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
3-Chloropyrazine-2-carboxylic acid · CAS 27398-39-6 · C5H3ClN2O2.
| CAS Registry Number | 27398-39-6 |
|---|---|
| PubChem CID | 1501900 |
| Molecular formula | C5H3ClN2O2 |
| IUPAC name | 3-chloropyrazine-2-carboxylic acid |
| Molecular Weight | 158.54 |
|---|---|
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 157.9883050 |
| Monoisotopic Mass | 157.9883050 |
| Topological Polar Surface Area | 63.1 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (40%), H312 (40%), H315 (60%), H319 (100%), H332 (40%), H335 (60%) |
|---|
H302 (40%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (40%): Harmful in contact with skin [Warning Acute toxicity, dermal]
3-Chloro-2-pyrazine-carboxylic acid; RefChem:499825; 676-250-5; 3-chloropyrazine-2-carboxylic Acid; 27398-39-6; 3-chloro-2-pyrazinecarboxylic acid; MFCD01318438; 3-chloro-pyrazine-2-carboxylic acid; Pyrazinecarboxylic acid, 3-chloro-; 2-Chloropyrazine-3-carboxylic acid; 3-Chloro-2-pryazine-carboxylic acid; SCHEMBL569230; RARECHEM AL BO 0855; CHEMBL5184581; SCHEMBL30042917; 3-chloropyrazine-2-carboxylicacid
CAS 27398-39-6; molecular formula C5H3ClN2O2; molecular weight — g/mol.
3-Chloro-2-pyrazine-carboxylic acid, RefChem:499825, 676-250-5, 3-chloropyrazine-2-carboxylic Acid, 27398-39-6, 3-chloro-2-pyrazinecarboxylic acid.
Hazard statements reported: H302, H312, H315, H319, H332.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.